£134m acquisition opens up European export market

A bio-tech group which has merged with a European animal health company expects the £134m acquisition to boost exports and allow the company to focus on product development. Animalcare Group completed a reverse takeover of Belgium-based Ecuphar in the summer, which has trebled the size of the business. In the year to June, just before the Ecuphar deal was agreed, Animalcare's underlying profits rose 12% to £3.6m. Revenues for the same period increased 8% to £15.9m. York-based Animalcare also revealed six-month figures fo... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
Close